Funder
National Institutes of Health
Subject
Cancer Research,Genetics,Molecular Biology,Molecular Medicine
Reference33 articles.
1. Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer;Andre;N. Engl. J. Med.,2019
2. The regulation of class IA PI 3-kinases by inter-subunit interactions;Backer;Curr. Top. Microbiol. Immunol.,2010
3. Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial;Baselga;Lancet Oncol.,2017
4. PI3K isoforms in cell signalling and vesicle trafficking;Bilanges;Nat. Rev. Mol. Cell Biol.,2019
5. Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110alpha (PIK3CA);Burke;Proc. Natl. Acad. Sci. U. S. A.,2012
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献